Cassava Sciences, Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Cassava Sciences, Inc.
- Company name
- Cassava Sciences, Inc.
- Organisation type
- Industry
- Registered legal name
- FILANA THERAPEUTICS, INC.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- Website
- https://www.cassavasciences.com/
- SEC filer number (CIK)
- 0001069530
- Wikidata ID
- Q111982872
Related records
Trials (9)
- A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function
- Food Effect and Bioequivalence Study of Simufilam Tablets in Healthy Volunteers
- Open-label Extension for Phase 3 Clinical Trials of Simufilam
- Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease
- Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male Subjects
- PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
- Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients
- Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease
- Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease